Advertisement
Advertisement

INTS

INTS logo

Intensity Therapeutics, Inc. Common stock

5.30
USD
Sponsored
-0.06
-1.12%
Apr 15, 16:00 UTC -4
Closed
exchange

Pre-Market

5.36

+0.06
+1.13%

Intensity Therapeutics, Inc. Common stock Profile

About

Intensity Therapeutics Inc. is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. Intensity leverages its DfuseRx(SM) technology platform to create new, proprietary drug formulations, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity Therapeutics Inc. is based in WESTPORT, Conn.

Info & Links

CEO

Lewis H. Bender

Headquarters

1 ENTERPRISE DRIVE, SUITE 430
SHELTON, CT 06484, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.intensitytherapeutics.com

Auditor

EisnerAmper LLP

Share holders

--

Employees

7

Intensity Therapeutics, Inc. Common stock Statistics

Valuation Measures

Market Capitalization2

13.62M

Enterprise Value

6.67M

Enterprise Value/EBITDA(ttm)

-0.56

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.13

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-214.77%

Return on Invested Capital(ttm)

-941.05%

Return on Assets(ttm)

-148.82%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-12.01M

Net Income Available to Common(ttm)

-11.74M

Diluted EPS(ttm)

-15.75

Share Statistics

Beta (5Y Monthly)

3.65

52-Week Change

-88.90%

S&P 500 52-Week Change

33.12%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

2.40M

Dividend Yield

0.00%

Float4

2.36M

% Held by Insiders

7.10%

% Held by Institutions

3.74%

Balance Sheet

Total Cash(mrq)

7.07M

Total Cash Per Share(mrq)

2.94

Total Debt(mrq)

118.00K

Total Debt/Equity(mrq)

0.93%

Current Ratio(mrq)

5.92%

Quick Ratio(mrq)

5.92%

Book Value Per Share(mrq)

4.71

Cash Flow

Operating Cash Flow Per Share(ytd)

-6.81

Free Cash Flow(ytd)

-9.23M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement